Guggenheim Capital LLC cut its stake in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 32.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,070 shares of the semiconductor company's stock after selling 2,875 shares during the quarter. Guggenheim Capital LLC's holdings in Silicon Laboratories were worth $754,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in SLAB. Norges Bank bought a new stake in Silicon Laboratories in the fourth quarter valued at approximately $34,622,000. Invesco Ltd. boosted its stake in shares of Silicon Laboratories by 46.9% in the 4th quarter. Invesco Ltd. now owns 595,382 shares of the semiconductor company's stock valued at $73,958,000 after purchasing an additional 190,085 shares during the last quarter. Raymond James Financial Inc. bought a new position in Silicon Laboratories during the fourth quarter worth $14,252,000. Alliancebernstein L.P. boosted its position in Silicon Laboratories by 58.2% during the fourth quarter. Alliancebernstein L.P. now owns 240,321 shares of the semiconductor company's stock valued at $29,853,000 after acquiring an additional 88,438 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in Silicon Laboratories by 1.9% during the 4th quarter. Vanguard Group Inc. now owns 3,959,580 shares of the semiconductor company's stock worth $491,859,000 after acquiring an additional 71,942 shares during the period.
Wall Street Analysts Forecast Growth
SLAB has been the subject of a number of research analyst reports. Barclays lowered their target price on Silicon Laboratories from $120.00 to $80.00 and set an "equal weight" rating for the company in a report on Tuesday, April 22nd. Needham & Company LLC restated a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a report on Wednesday, March 12th. KeyCorp upped their price objective on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an "overweight" rating in a report on Wednesday, January 22nd. Stifel Nicolaus reduced their price target on shares of Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a research report on Thursday, April 17th. Finally, Benchmark restated a "buy" rating and set a $160.00 price objective on shares of Silicon Laboratories in a report on Wednesday, March 12th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $129.00.
Get Our Latest Research Report on SLAB
Insider Buying and Selling at Silicon Laboratories
In other news, Director William G. Bock sold 1,000 shares of the company's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now owns 31,115 shares of the company's stock, valued at $4,649,514.45. This represents a 3.11 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Navdeep S. Sooch sold 2,360 shares of the company's stock in a transaction on Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the sale, the director now directly owns 400,567 shares of the company's stock, valued at approximately $59,684,483. This trade represents a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.
Silicon Laboratories Stock Performance
Shares of NASDAQ:SLAB traded down $0.39 during midday trading on Tuesday, reaching $102.23. 43,919 shares of the company's stock traded hands, compared to its average volume of 325,209. Silicon Laboratories Inc. has a 1 year low of $82.82 and a 1 year high of $160.00. The company has a market cap of $3.32 billion, a P/E ratio of -17.16 and a beta of 1.33. The company has a fifty day simple moving average of $115.59 and a two-hundred day simple moving average of $120.99.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.11). The firm had revenue of $166.25 million during the quarter, compared to analysts' expectations of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The business's quarterly revenue was up 91.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($1.19) earnings per share. As a group, research analysts forecast that Silicon Laboratories Inc. will post -0.97 EPS for the current fiscal year.
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Recommended Stories

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report